Wednesday, September 27, 2017

Researchers Create New MR Contrast Agent That Can Locate And Differentiate Between Aggressive And Slow-Growing Breast Cancer.

DOT Med News (9/26, Fischer) reports that scientists “have created a new MR contrast agent that can locate and differentiate between aggressive and slow-growing, low-risk types of breast cancer at early stages.” According to DOT Med News, “The gadolinium-based agent lights up cancer biomarkers during scans, overcoming the low sensitivity of MR for imaging markers, and produces signals with different shades ofbrightness that contrast aggressive from slow-growing, low-risk types of cancer.” The research was published in Nature Communications.

Author: Alan Boyce

Categories: 2017, September, News, Research and CareNumber of views: 4722


Theme picker